Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04100408

Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)

Sponsor: Children's Oncology Group

View on ClinicalTrials.gov

Summary

The long-term goal is to define the mechanisms of pathogenesis underlying Langerhans cell histiocytosis (LCH). The overall objectives of the current study are to characterize the role of SMAD6 inherited genetic variation on LCH susceptibility and identify germline genomic regions associated with LCH somatic mutations. Building from preliminary data, the central hypotheses are: (1) causal genetic variants in SMAD6 underlie susceptibility to LCH, and (2) differences in LCH-related somatic activating mutations by race/ethnicity are related to Amerindian (i.e., Native American) genetic ancestry. The Central hypothesis will be tested by pursuing the specific aims.

Key Details

Gender

All

Age Range

Any - 25 Years

Study Type

OBSERVATIONAL

Enrollment

647

Start Date

2020-06-01

Completion Date

2026-09-30

Last Updated

2026-01-09

Healthy Volunteers

No

Interventions

OTHER

Biospecimen Collection

Undergo saliva or buccal mucosa collection

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Questionnaire Administration

Ancillary studies

Locations (1)

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Houston, Texas, United States